Anne Doering
Director of Finance/CFO at VIVORYON THERAPEUTICS N.V.
Net worth: - $ as of 31/05/2024
Profile
Anne Marie Doering is currently the Chief Financial Officer & Executive Director at Vivoryon Therapeutics NV.
She previously worked as the Director-Investor Relation at BioNTech SE, Director-Group Strategy at Merck KGaA, and Investment Manager at Creathor Venture Management GmbH.
From 2010 to 2019, she served as a Portfolio Manager & Research Analyst at Franklin Templeton Investment Management Ltd.
(Germany).
Ms. Doering holds a graduate degree from the University of Pennsylvania, a graduate degree from the Joseph H Lauder Institute of Management & International, and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 06/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Anne Doering active positions
| Companies | Position | Start |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Director of Finance/CFO | 01/03/2024 |
Former positions of Anne Doering
| Companies | Position | End |
|---|---|---|
Franklin Templeton Investment Management Ltd. (Germany)
 Franklin Templeton Investment Management Ltd. (Germany) Investment ManagersFinance Franklin Templeton Investment Management Ltd. (Germany) (FTIML-Germany) is the German investment management division of Great Britain-based Franklin Templeton Investment Management Ltd., ultimately owned by Franklin Resources, Inc. (NYSE: BEN) in the US. Headquartered in Frankfurt, the firm was founded in 1992 and manages the Franklin Templeton Investments fund range for individuals, pension funds, trusts, local authorities, corporations, government bodies, fund of funds and multi-managers. | Analyst-Equity | 01/01/2019 |
Creathor Venture Management GmbH
 Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Private Equity Investor | 01/11/2010 |
| MERCK KGAA | Corporate Officer/Principal | - |
| BIONTECH SE | Investor Relations Contact | - |
Training of Anne Doering
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Joseph H Lauder Institute of Management & International | Graduate Degree |
| University of Pennsylvania | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| VIVORYON THERAPEUTICS N.V. | Health Technology |
| BIONTECH SE | Health Technology |
| MERCK KGAA | Health Technology |
| Private companies | 2 |
|---|---|
Creathor Venture Management GmbH
Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Finance |
Franklin Templeton Investment Management Ltd. (Germany)
Franklin Templeton Investment Management Ltd. (Germany) Investment ManagersFinance Franklin Templeton Investment Management Ltd. (Germany) (FTIML-Germany) is the German investment management division of Great Britain-based Franklin Templeton Investment Management Ltd., ultimately owned by Franklin Resources, Inc. (NYSE: BEN) in the US. Headquartered in Frankfurt, the firm was founded in 1992 and manages the Franklin Templeton Investments fund range for individuals, pension funds, trusts, local authorities, corporations, government bodies, fund of funds and multi-managers. | Finance |
- Stock Market
- Insiders
- Anne Doering
